TDOC
Teladoc Health, Inc.NYSEHealthcare$5.27-0.19%OpenMarket Cap: $940.1M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.67
P/S
0.37
EV/EBITDA
124.40
DCF Value
$20.32
FCF Yield
24.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
69.5%
Operating Margin
-10.4%
Net Margin
-7.9%
ROE
-14.2%
ROA
-13.2%
ROIC
-8.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $642.3M | 69.3% | $-36.0M | $-25.1M | $-0.14 | — |
| FY 2025 | $2.53B | 69.5% | $-263.0M | $-200.3M | $-1.14 | — |
| Q3 2025 | $626.4M | 70.1% | $-52.0M | $-49.5M | $-0.28 | — |
| Q2 2025 | $631.9M | 69.8% | $-54.4M | $-32.7M | $-0.19 | — |
| Q1 2025 | $629.4M | 68.7% | $-120.6M | $-93.0M | $-0.53 | — |
| Q4 2024 | $640.5M | 70.5% | $-48.2M | $-48.4M | $-0.28 | — |
| FY 2024 | $2.57B | 70.8% | $-1.02B | $-1.00B | $-5.87 | — |
| Q3 2024 | $640.5M | 71.9% | $-44.4M | $-33.3M | $-0.19 | — |
| Q2 2024 | $642.4M | 70.7% | $-841.1M | $-837.7M | $-4.92 | — |
| Q1 2024 | $646.1M | 69.9% | $-87.1M | $-81.9M | $-0.49 | — |
| Q4 2023 | $660.5M | 70.7% | $-35.1M | $-28.9M | $-0.17 | — |
| FY 2023 | $2.60B | 70.8% | $-248.6M | $-220.4M | $-1.34 | — |